TERUMO VIETNAM CO., LTD (CÔNG TY TNHH TERUMO VIỆT NAM) is a wholly foreign-owned enterprise operating under Tax Code 2500254567, officially registered on April 25, 2006, with the Hanoi City Department of Planning and Investment. Located at Lot 44A-44B-44C, Quang Minh Industrial Park, Chi Dong Town, Me Linh District, Ha Noi City, Vietnam, the company has become a critical part of the global supply chain in medical equipment manufacturing.

As a member of Japan’s renowned Terumo Corporation, which holds 100% ownership, the Vietnam subsidiary functions as a core manufacturing base in Asia. The company’s operations focus on producing and trading medical, dental, orthopedic, and rehabilitation instruments and supplies—a sector that requires high levels of regulatory compliance, precision engineering, and technological investment.

In the fiscal year ending March 2023, TERUMO VIETNAM recorded USD 171.79 million in sales, showing a modest 2.86% increase over the previous year. Net profit rose to USD 16.9 million, reflecting a 14.08% growth, while total assets climbed to USD 260.53 million, up 15.2% year-over-year. The company's owner’s equity reached USD 171.2 million, and working capital stood strong at USD 121.63 million, reinforcing its position as a financially secure and well-capitalized operation.

The firm employs approximately 2,500 workers, making it a major industrial employer in the Hanoi area. Day-to-day operations are overseen by General Director Uchida T., a Japanese national, who steers the company with a focus on global quality standards and continuous improvement in production.

Given the size, sector, and financial robustness of the company, TERUMO VIETNAM CO., LTD is considered a low-risk partner for buyers, suppliers, and investors seeking long-term engagement in the healthcare manufacturing space. For added assurance, clients are encouraged to request a full Vietnam Company Report, Business Verification, or Risk Management Services from VANGUARD BUSINESS INFORMATION LLC (VBI)—particularly when entering procurement, distribution, or contractual agreements.

With nearly two decades of operation, TERUMO VIETNAM stands as a strong example of how foreign direct investment in Vietnam can generate both economic value and medical innovation.